Eight-hour early versus late eating windows to improve blood sugar and cardiometabolic health in overweight adults
Official title: Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes: the GLYCOTIME Trial
Run by German Institute of Human Nutrition · NCT07171281 · Data updated 2026-11-12
We will try early versus late 8-hour time-restricted eating with moderate calorie reduction to see if it improves blood sugar and heart-related health in adults who are overweight with normal glucose, prediabetes, or non-insulin-treated type 2 diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | German Institute of Human Nutrition Academic / other |
| Locations | 1 site (Nuthetal) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | February 28, 2028 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07171281 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with BMI 25–40 kg/m² who currently eat across at least 12 hours per day and have normal glucose, prediabetes, or non-insulin-treated type 2 diabetes, and who can attend on-site visits.
✕Probably not a fit
People on insulin, recent major illness or cardiovascular events, shift workers, pregnant or breastfeeding people, those already practicing time-restricted eating, or those with incompatible medical conditions are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a crossover dietary intervention where participants follow two 5-week hypocaloric, 8-hour eating-window diets: one window predominantly in the morning (early TRE) and one predominantly in the afternoon (late TRE). A 10–12 week washout separates the intervention periods to reduce carryover effects. The study measures glucose metabolism and a range of cardiometabolic parameters, and collects biological samples to explore molecular mechanisms. Participants include adults with BMI 25–40 kg/m² who have normal glucose, prediabetes, or type 2 diabetes not treated with insulin.
Why it matters
Potential benefit: If successful, it could offer a low-cost, medication-free way to improve blood sugar control and reduce cardiometabolic risk by changing when people eat.
How similar studies have gone: Previous time-restricted eating trials have shown weight loss and improvements in some metabolic markers, but direct comparisons of early versus late windows and detailed molecular mechanism data are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Overweight or obesity (BMI 25-40 kg/m²) * Healthy glucose metabolism (fasting glucose \<100 mg/dl and glucose after 2 hours OGTT \<140 mg/dl) * OR impaired glucose metabolism (fasting glucose 100-125 mg/dl and/or glucose after 2 hours OGTT 140-199 mg/dl and/or HbA1c 5.7-6.4%) * OR type 2 diabetes (according to existing medical diagnosis or fasting glucose \>126 mg/dl and/or glucose after 2 hours OGTT \>200 mg/dl and/or HbA1c ≥6.5%) * Daily eating window ≥12 hours Exclusion Criteria: * Weight changes \> 5% within past 3 months * Shift work * Traveling across more than one time zone within one month prior to the study * Pregnancy and breastfeeding * Eating disorders, food intolerance/allergy to ingredients in the diet product, vegan diet, practicing time-restricted eating * Severe chronic illnesses or other conditions that are incompatible with the planned intervention and examination program (e.g. type 1 diabetes, recent cardiovascular event, malabsorption, cancer in the last two years, etc.) * Treatment with insulin, sulfonylureas, and GLP-1 receptor agonists, steroid use (oral, cutaneous, or parenteral), regular intake of melatonin, anticoagulation treatment that cannot be paused * Extreme early and extreme late chronotypes
Where it's running
-
German Institute of Human Nutrition Potsdam-Rehbruecke
Nuthetal, Germany Recruiting
Study contacts
- Study coordinator: Olga Ramich, Prof. Dr.
- Email: olga.ramich@dife.de
- Phone: +49 33200 882749
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
-
Switching to Zenagamtide from Semaglutide in adults with overweight or obesity, with or without type 2 diabetes
This study tests whether adults who are already taking semaglutide can successfully switch to zenagamtide at different doses to see which dose works best.
-
Supervised exercise after bariatric surgery to protect muscle and bone
This program tests whether supervised exercise after gastric bypass or sleeve surgery helps preserve muscle mass and bone density in adults.
-
Comparing a standard versus an intensified interactive Get Ready app to support patients having bariatric surgery
This trial tests whether an intensified, interactive version of the Get Ready smartphone app helps people having bariatric surgery follow their pre- and post‑operative plan better than the standard app.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.